We have posted pre-clinical results with ALN-AT3, an investigational RNAi healing targeting antithrombin (AT) for the treatment of hemophilia, in Dynamics Medicine. The newspaper documents a broad group of pre-clinical data helping the cli…
Quote saved.
Login to quote this blog
Failed to save quote. Please try again later.
You cannot quote because this article is private.